Heartcore Capital closes $180 million fund to focus on infrastructure, synthetic biology and climate
[ad_1] Back in the joyful days of 2021, Heartcore Capital It plans to focus on consumer technology with a $200 ...
Read more
Orakl Oncology combines data and biology to deliver new medicines to cancer patients
[ad_1] Cancer rates are rising, especially among younger adults, but most new drug compounds fail to advance through clinical trials. ...
Read more